Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat

European Journal of Pharmacology

Volumn 514, Issue 2-3, 2005, Pages 159-164

  Naderi, Nima ^a   Shafaghi, Bijan ^a   Khodayar, Mohammad Javad ^a   Zarindast, Mohammad Reza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

(Rat); Antinociceptive; Cannabinoid CB1 receptor; GABAB receptor; Spinal cord

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; FORMALDEHYDE; RIMONABANT; SACLOFEN;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL ANESTHESIA; SPINAL PAIN;

ANALYSIS OF VARIANCE; ANIMALS; BACLOFEN; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FORMALDEHYDE; GABA AGONISTS; GABA ANTAGONISTS; INJECTIONS, SPINAL; MALE; PAIN; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GABA-B; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 19344373146     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.037     Document Type: Article

References (25)

1. S. Aran, and D.L. Hammond Antagonism of baclofen induced antinociception of phaclofen or 2-hydroxy saclofen, but not delta-aminovaleric acid in the rat J. Pharmacol. Exp. Ther. 257 1991 360 368
2. D. Bridges, A.S. Rice, M. Egertova, M.R. Elphick, J. Winter, and G.J. Michael Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry Neuroscience 119 2003 803 812
3. J.L. Croxford Therapeutic potential of cannabinoids in CNS disease CNS Drugs 17 2003 179 202
4. D.M. Dirig, and T.L. Yaksh Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model J. Pharmacol. Exp. Ther. 275 1995 219 227
5. D. Dubuisson, and S.G. Dennis The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain 4 1977 161 174
6. G. Griffin, P.J. Atkinson, V.M. Showalter, B.R. Martin, and M.E. Abood Evaluation of cannabinoid receptor agonists using the guanosine-5′-o-(3- [35S]thio)-triphosphate binding assay in rat cerebellar membranes J. Pharmacol. Exp. Ther. 285 1998 553 560
7. D.L. Hammond, and E.J. Drower Effects of intrathecally administered THIP, baclofen, and muscimol on nociceptive threshold Eur. J. Pharmacol. 103 1984 121 125
8. D.L. Hammond, and J.D. Washington Antagonism of L-baclofen-induced antinociception by CGP 35348 in the spinal cord of the rat Eur. J. Pharmacol. 234 1993 255 262
9. A.G. Hohmann, and M. Herkenham Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study Neuroscience 90 1999 923 931
10. J.H. Hwang, and T.L. Yaksh The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat Pain 70 1997 15 22
11. E.A. Jennings, C.W. Vaughan, and M.J. Christie Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro J. Physiol. 534 2001 805 812
12. T.W. Klein, C.A. Newton, and H. Friedman Cannabinoids and the immune system Pain Res. Manag. 6 2001 95 101
13. R.S. Landsman, T.H. Burkey, P. Consroe, W.R. Roeske, and H.I. Yamamura SR141716A is an inverse agonist at the human cannabinoid CB1 receptor Eur. J. Pharmacol. 334 1997 R1 R2
14. B.R. Martin, and A.H. Lichtman Cannabinoid transmission and pain perception Neurobiol. Dis. 6 1998 447 461
15. E.C. Mbvundula, K.D. Rainsford, and R.A. Bunning Cannabinoids in pain and inflammation Inflammopharmacology 12 2004 99 114
16. I.D. Meng, B.H. Manning, W.J. Martin, and H.L. Fields An analgesia circuit activated by cannabinoids Nature 395 1998 381 383
17. J.D. Richardson, L. Aanonsen, and K.M. Hargreaves Antihyperalgesic effects of spinal cannabinoids Eur. J. Pharmacol. 345 1998 145 153
18. C. Salio, J. Fischer, M.F. Franzoni, and M. Conrath Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord Neuroscience 110 2002 755 764
19. R. Sharma, R. Marthur, and U. Nayar GABA(B) mediated analgesia in tonic pain in monkeys Indian J. Physiol. Pharmacol. 37 1993 189 193
20. N.M. Strangman, S.L. Patrick, A.G. Hohmann, K. Tsou, and J.M. Walker Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity Brain Res. 813 1998 323 328
21. A. Tjolsen, O.G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole The formalin test: an evaluation of the method Pain 51 1992 5 17
22. J.M. Walker, N.M. Strangman, and S.M. Huang Cannabinoids and pain Pain Res. Manag. 6 2001 74 79
23. S.P. Welch, and D.L. Stevens Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice J. Pharmacol. Exp. Ther. 262 1992 10 18
24. S.P. Welch, C. Thomas, and G.S. Patrick Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine J. Pharmacol. Exp. Ther. 272 1995 310 321
25. T.L. Yaksh, and T.A. Rudy Chronic catheterization of the spinal subarachnoid space Physiol. Behav. 17 1976 1031 1036